Biovista: Biotechnology, drug repositioning, Gene, Drug, Adverse event, Disease, Investigational New Generic

1/1
Prices from
108.41

Featured

COMPARE ALL WEBSHOPS (2)

Description

Biovista: Biotechnology, drug repositioning, Gene, Drug, Adverse event, Disease, Investigational New Generic

Description Description
Product Specifications Product specifications
Related results Related results
Next
Previous

Compare webshops (2)

Sort by:

€ 108.41

€ 108.41

Description (0)

Biovista: Biotechnology, drug repositioning, Gene, Drug, Adverse event, Disease, Investigational New Generic

Product specifications

Brand OmniScriptum
EAN
  • 9786133876347

OmniScriptum

EudraVigilance: Adverse event, Drug, European Economic Area

€ 127.10
Compare 2 stores 2 stores

OmniScriptum

Experimental Drug: Approved Drug, Food and Drug Administration, Investigational New Medical cannabis, Off-label use

€ 108.41
Compare 2 stores 2 stores

OmniScriptum

Patients Out of Time: Medical Marijuana, Investigational New Drug

€ 127.10
Compare 2 stores 2 stores

Independently Published

21 CFR MADE SIMPLE Volume 2: PART 312—INVESTIGATIONAL NEW DRUG APPLICATION

€ 29.58
Compare 2 stores 2 stores
Featured Choice
€ 108.41
To Shop